Friday, June 12, 2026

CGBio Reports Return to Operating Profit in 2025… Growth in Bone Substitutes and Dental Business

CGBio Co., Ltd. reported a $2.6M operating profit in 2025, reversing losses and achieving 36% revenue growth, driven by bone substitutes.

UN Security Council Scrambles After North Korean Satellite Disaster

Contrary to initial reports, the United Nations...

North Korean POW Says Going Home Means Death

Rep. Yoo Yong Won urges the government to act for two North Korean soldiers excluded from a prisoner exchange with Ukraine.

Tag: CT-P72/ABP-102

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CT-P72/ABP-102: The Next Big Breakthrough in HER2 Cancer Treatment?

Celltrion's CT-P72/ABP-102 shows strong efficacy against HER2 tumors, promising for treating various cancers with reduced toxicity.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.